葡萄糖皮质醇诱导的骨质疏松症:概述,重点关注其预防和管理
Eleni Anastasilaki1, Julien Paccou2, Konstantinos Gkastaris3
1School of Medicine, European University of Cyprus, Nicosia, Cyprus.
概括
葡萄糖皮质激素 (GCs) 有效地治疗疾病,但会导致骨质损失,导致葡萄糖皮质激素诱导的骨质疏松症 (GIOP). 早期风险分层和适当治疗的及时干预对于管理GIOP至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 骨的新陈代谢 骨的新陈代谢
- 药理学 药理学是指药理学的学科.
背景情况:
- 葡萄糖皮质类药物 (GCs) 广泛用于各种疾病.
- GCs可以引起葡萄糖皮质激素诱导的骨质疏松症 (GIOP),这是二次骨质疏松症和骨折的常见原因.
- 现有的指导方针涉及最佳的GIOP管理,包括预防措施和治疗启动.
研究的目的:
- 总结关于管理葡萄糖皮质醇诱导骨质疏松症 (GIOP) 的当前指南.
- 概述影响GIOP治疗决策的关键因素.
- 讨论可用的治疗选择及其考虑.
主要方法:
- 审查科学社会关于GIOP管理的指南.
- 对影响决定开始抗骨质疏松药物治疗的因素的分析.
- 首线治疗方法 (口服双酸盐,德诺苏马布) 和新兴疗法 (骨质类药物) 的比较.
主要成果:
- 预防措施应伴随GC启动;治疗持续时间应尽量减少.
- 治疗决定取决于骨折史,年龄,更年期状态,GC剂量和持续时间.
- 口服双酸盐是第一线药物;德诺苏马布需要退出策略;骨质合成药物是有前途的,但成本高昂.
结论:
- 最佳的GIOP管理需要及时的风险分层和干预.
- 必须平衡治疗效果,成本和潜在的副作用.
- 医生必须仔细选择疗法,以减轻GC诱导的骨损失.
相关概念视频
Hypoglycemia and Glucagon
287
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
287
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
144
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
144
COPD: Management Using Bronchodilators and Corticosteroids
236
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
236
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
289
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
289
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K


